These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 8524490)
1. Cellular mechanism of resistance to erythropoietin. Casadevall N Nephrol Dial Transplant; 1995; 10 Suppl 6():27-30. PubMed ID: 8524490 [TBL] [Abstract][Full Text] [Related]
2. R-h-erythropoietin counteracts the inhibition of in vitro erythropoiesis by tumour necrosis factor alpha in patients with rheumatoid arthritis. Jongen-Lavrencic M; Peeters HR; Backx B; Touw IP; Vreugdenhil G; Swaak AJ Rheumatol Int; 1994; 14(3):109-13. PubMed ID: 7839070 [TBL] [Abstract][Full Text] [Related]
3. Effects of interleukin-3 and erythropoietin on in vivo erythropoiesis and F-cell formation in primates. Umemura T; al-Khatti A; Donahue RE; Papayannopoulou T; Stamatoyannopoulos G Blood; 1989 Oct; 74(5):1571-6. PubMed ID: 2477080 [TBL] [Abstract][Full Text] [Related]
4. Effects of monocyte-macrophage colony-stimulating factor (M-CSF) on in vitro erythropoiesis of marrow progenitor cells from patients with renal anemia. Kawano Y; Takaue Y; Minakuchi J; Kawashima S; Kimura F; Motoyoshi K; Abe T; Sato J; Hirao A; Saito S Eur J Haematol; 1995 Mar; 54(3):147-52. PubMed ID: 7720833 [TBL] [Abstract][Full Text] [Related]
5. Guinea pig serum erythropoietin (EPO) selectively stimulates guinea pig erythroid progenitors: human or mouse erythroid progenitors do not form erythroid burst-forming unit colonies in response to guinea pig serum EPO. Stopka T; Zivny JH; Goldwasser E; Prchal JF; Necas E; Prchal JT Exp Hematol; 1998 Aug; 26(9):910-4. PubMed ID: 9694513 [TBL] [Abstract][Full Text] [Related]
6. Effect of Tumor Necrosis Factor-Alpha on Erythropoietin and Erythropoietin Receptor-Induced Erythroid Progenitor Cell Proliferation in β-Thalassemia/Hemoglobin E Patients. Tanyong DI; Panichob P; Kheansaard W; Fucharoen S Turk J Haematol; 2015 Dec; 32(4):304-10. PubMed ID: 26376749 [TBL] [Abstract][Full Text] [Related]
7. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation. Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110 [TBL] [Abstract][Full Text] [Related]
8. The mechanism of expansion of late erythroid progenitors during erythroid regeneration: target cells and effects of erythropoietin and interleukin-3. Umemura T; Papayannopoulou T; Stamatoyannopoulos G Blood; 1989 May; 73(7):1993-8. PubMed ID: 2785421 [TBL] [Abstract][Full Text] [Related]
9. In vivo suppression of erythropoiesis by tumor necrosis factor-alpha (TNF-alpha): reversal with exogenous erythropoietin (EPO). Johnson CS; Cook CA; Furmanski P Exp Hematol; 1990 Feb; 18(2):109-13. PubMed ID: 2303102 [TBL] [Abstract][Full Text] [Related]
10. Effects of five recombinant hematopoietic growth factors on enriched human erythroid progenitors in serum-replaced cultures. Mitjavila MT; Natazawa M; Brignaschi P; Debili N; Breton-Gorius J; Vainchenker W J Cell Physiol; 1989 Mar; 138(3):617-23. PubMed ID: 2647773 [TBL] [Abstract][Full Text] [Related]
11. PPAR-α and glucocorticoid receptor synergize to promote erythroid progenitor self-renewal. Lee HY; Gao X; Barrasa MI; Li H; Elmes RR; Peters LL; Lodish HF Nature; 2015 Jun; 522(7557):474-7. PubMed ID: 25970251 [TBL] [Abstract][Full Text] [Related]
12. Effect of the interaction between transforming growth factor beta and erythropoietin on the proliferation of normal erythroid progenitors and leukemic UT-7 cells: action of transforming growth factor beta on the erythropoietin receptor. Leveque E; Nagel MD; Haye B Hematol Oncol; 1996 Sep; 14(3):137-46. PubMed ID: 9119358 [TBL] [Abstract][Full Text] [Related]
13. In vitro enhancement of erythropoiesis by steel factor in Diamond-Blackfan anemia and treatment of other congenital cytopenias with recombinant interleukin 3/granulocyte-macrophage colony stimulating factor. Sieff C; Guinan E Stem Cells; 1993 Jul; 11 Suppl 2():113-22. PubMed ID: 7691316 [TBL] [Abstract][Full Text] [Related]
14. Effects of erythropoietin and recombinant cytokines on colony formation and self-renewal by erythroid burst-forming units and granulocyte-macrophage progenitors from mobilized peripheral blood progenitor cells. Zheng B Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Feb; 10(1):6-12. PubMed ID: 12513828 [TBL] [Abstract][Full Text] [Related]
15. In vivo effects of interleukin-11 and stem cell factor in combination with erythropoietin in the regulation of erythropoiesis. de Haan G; Dontje B; Engel C; Loeffler M; Nijhof W Br J Haematol; 1995 Aug; 90(4):783-90. PubMed ID: 7545423 [TBL] [Abstract][Full Text] [Related]
16. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro. Tanimukai S; Kimura T; Sakabe H; Ohmizono Y; Kato T; Miyazaki H; Yamagishi H; Sonoda Y Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899 [TBL] [Abstract][Full Text] [Related]
17. Renal anaemia and EPO hyporesponsiveness associated with vitamin D deficiency: the potential role of inflammation. Icardi A; Paoletti E; De Nicola L; Mazzaferro S; Russo R; Cozzolino M Nephrol Dial Transplant; 2013 Jul; 28(7):1672-9. PubMed ID: 23468534 [TBL] [Abstract][Full Text] [Related]
18. Recombinant human granulocyte colony-stimulating factor increases circulating burst forming unit-erythron and red blood cell production in patients with severe human immunodeficiency virus infection. Miles SA; Mitsuyasu RT; Lee K; Moreno J; Alton K; Egrie JC; Souza L; Glaspy JA Blood; 1990 Jun; 75(11):2137-42. PubMed ID: 1693297 [TBL] [Abstract][Full Text] [Related]
19. Human interleukin (IL)-9 specifically stimulates proliferation of CD34+++DR+CD33- erythroid progenitors in normal human bone marrow in the absence of serum. Lu L; Leemhuis T; Srour EF; Yang YC Exp Hematol; 1992 May; 20(4):418-24. PubMed ID: 1373687 [TBL] [Abstract][Full Text] [Related]
20. Cessation of intensive treatment with recombinant human erythropoietin is followed by secondary anemia. Piron M; Loo M; Gothot A; Tassin F; Fillet G; Beguin Y Blood; 2001 Jan; 97(2):442-8. PubMed ID: 11154221 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]